학술논문
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
Document Type
Article
Author
Source
In European Journal of Cancer July 2018 97:7-15
Subject
Language
ISSN
0959-8049